TraceLink Achieves Highest Revenue in Q3 2017, Driven by Record Growth of Over 230% in EMEA and India
TraceLink announces financial and company results for the third quarter of 2017, revealing an 84% year-over-year increase in revenue, driven by record growth in EMEA and India. TraceLink now has over 700 customers, spanning all segments within the global pharmaceutical supply chain.
Deloitte and CPhI are Latest to Recognize TraceLink for its Industry Leadership, Growth and Innovation
TraceLink makes the Deloitte Fast 500 list for the 3rd consecutive year, named as the #177 fastest growing company in North America due to its 611% revenue growth. In October, CPhI Worldwide recognized TraceLink as the gold recipient of the annual CPhI Pharma awards, honored for pharma excellence in supply chain, logistics and distribution. TraceLink has received 7 industry awards in 2017.
The Biogen Story: Switching to TraceLink for Serialization
The need to meet EU FMD requirements, plus other key criteria, led multi-national biotech company Biogen to reassess vendors and ultimately choose TraceLink. Bjoern Rosner, Associate Director of Global Brand Protection, explains how they knew it was time to make a switch.